Fundraising Fox

Genghis Lloyd-Harris

Investor

Partner at Abingworth

London

Writes $15M – $30M checks · typically $22.5M

About

Genghis Lloyd-Harris is a Senior Advisor to Abingworth and formerly a Partner, where his work centered on exiting venture investments through M&A and IPOs. He joined Abingworth in 2004 from Credit Suisse First Boston, where he was a Managing Director in the European Equity Research Group in London covering the biotechnology industry, having earlier worked in CSFB's Health Care investment banking group in New York. He previously practiced as a paediatrician in Melbourne and holds a Medical Degree from the University of Liverpool, a PhD in Clinical Pharmacology from the University of Melbourne, and an MBA from Harvard Business School.

LinkedIn ↗

Invests in

Biotech

Experience

  1. Cancer Research HorizonsInvestor-In-Residencecurrent2023 — presentLondon
  2. ClotProtectChairmancurrent2024 — presentLeeds, UK
  3. Lean Life ScienceSenior Advisorcurrent2023 — presentManchester
  4. Harvard Medical SchoolReviewercurrent2024 — presentBoston, Massachusetts, United States
  5. AbingworthSenior Advisorcurrent2023 — presentLondon
  6. AbingworthPartner2004 — 2023London
  7. Credit Suisse First Boston (now UBS)Managing Director, Equity Research, Biotechnology1994 — 2004London
  8. Credit Suisse First Boston (now UBS)Vice President, Investment Banking, Pharma/Biotech1989 — 1994New York

Education

  1. Harvard Graduate School of Business AdministrationMBA1987 — 1989
  2. University of MelbournePhD, Clinical pharmacology1984 — 1987
  3. Liverpool University Medical SchoolMB ChB, Medicine and Surgery1974 — 1980

Skills & more

Strategy3IPO25Venture Capital51Equities10Mergers6Investment Banking19Mergers & Acquisitions19Joint Ventures1Financial Modeling2Equity Research6Private Equity8Investments4
+12 moreFinancial AnalysisM&A experienceAsset ManagementDue DiligenceLBOBusiness StrategyCapital MarketsBiotechnologyEntrepreneurshipBloombergPharmaceutical IndustryBoard of Directors

From Genghis's professional profile.

Same school

Also attended University of Melbourne185

Kevin JohnsonInvestor at MedicxiEsther GilmoreGlobal Head of the Client Team at Generation Investment ManagementMark MillsClient Team Member at Generation Investment ManagementPaulInvestor at Square Peg CapitalDan KrasnosteinPartner at Square Peg CapitalLeila LeePartner & Head of Distribution at Square Peg Capital

+ 179 more

Shared employers

Also worked at Cancer Research Horizons1

Carlos Garcia-EcheverriaVenture Partner at Ysios Capital

Also worked at Harvard Medical School116

Logan HilleLife Sciences Analyst at CincyTechAnkit GuptaGeneral Partner at Y CombinatorDavid MollerInvestor at Third Rock VenturesJulie YangInvestor at Third Rock VenturesTracy WilliamsInvestor at Third Rock VenturesSamuel ArbesmanVenture Partner at Lux Capital

+ 110 more

Also worked at Abingworth17

Carlos PayaVenture Partner at Ysios CapitalSarah ShackeltonAdvisor at Delin VenturesBali MuralidharGlobal Head of Life Sciences & CIO at AbingworthKurt von EmsterManaging Partner at AbingworthJayson PunwaniManaging Director, Head of Venture at AbingworthAndrew SinclairManaging Director, Head of Publics & Late Stage at Abingworth

+ 11 more

Deals · 1

Gensight Biologics S.ABoard seat

via Abingworth · filed Jul 2015 · $25M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Abingworth

Alex Asquith
Counsel at Abingworth
Andrew Sinclair
Managing Director, Head of Publics & Late Stage at Abingworth
Ankur Shah
Vice President, CCD at Abingworth
Anna Slezak
Senior Associate at Abingworth
Bali Muralidhar
Global Head of Life Sciences & CIO at Abingworth
Carlos Paya
Venture Partner at Abingworth
Dayle Hogg
Operating Executive at Abingworth
Diya Malhotra
Principal at Abingworth

Network5

Andrew Sinclair
Managing Director, Head of Publics & Late Stage at Abingworth
Diya Malhotra
Principal at Abingworth
Jacqueline Grant
Principal at Abingworth
Jay Cui
Principal at Abingworth
Jayson Punwani
Managing Director, Head of Venture at Abingworth

Investors connected to Genghis in public investor directories — a warm-intro map.